Onsdag 25 Mars | 06:42:16 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2023-02-22 - Bokslutskommuniké 2022
2022-12-05 - Extra Bolagsstämma 2022
2022-07-21 - Kvartalsrapport 2022-Q2
2022-05-31 - Årsstämma
2022-05-06 - X-dag ordinarie utdelning KARO 0.00 SEK
2022-02-25 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-22 - Kvartalsrapport 2021-Q2
2021-04-23 - X-dag ordinarie utdelning KARO 0.00 SEK
2021-04-21 - Årsstämma
2021-04-21 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-07-21 - Kvartalsrapport 2020-Q2
2020-05-25 - Årsstämma
2020-04-30 - X-dag ordinarie utdelning KARO 0.00 SEK
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-11-15 - Kvartalsrapport 2019-Q3
2019-09-20 - Extra Bolagsstämma 2019
2019-07-19 - Kvartalsrapport 2019-Q2
2019-05-17 - X-dag ordinarie utdelning KARO 0.00 SEK
2019-05-16 - Årsstämma
2019-04-26 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018
2018-11-01 - Kvartalsrapport 2018-Q3
2018-07-19 - Kvartalsrapport 2018-Q2
2018-05-04 - X-dag ordinarie utdelning KARO 0.30 SEK
2018-05-03 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-02-22 - Bokslutskommuniké 2017
2017-12-08 - Extra Bolagsstämma 2017
2017-11-02 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-12 - X-dag ordinarie utdelning KARO 0.28 SEK
2017-05-12 - X-dag bonusutdelning KARO 0.22
2017-05-11 - Årsstämma
2017-05-10 - Kvartalsrapport 2017-Q1
2017-02-28 - Bokslutskommuniké 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-07-15 - Kvartalsrapport 2016-Q2
2016-05-13 - X-dag ordinarie utdelning KARO 0.00 SEK
2016-05-12 - Årsstämma
2016-05-12 - Kvartalsrapport 2016-Q1
2016-03-16 - Extra Bolagsstämma 2016
2016-02-12 - Bokslutskommuniké 2015
2015-10-29 - Kvartalsrapport 2015-Q3
2015-08-26 - Split KARO 20:1
2015-07-10 - Kvartalsrapport 2015-Q2
2015-04-30 - X-dag ordinarie utdelning KARO 0.00 SEK
2015-04-29 - Årsstämma
2015-04-29 - Kvartalsrapport 2015-Q1
2015-02-13 - Bokslutskommuniké 2014
2014-10-29 - Kvartalsrapport 2014-Q3
2014-07-11 - Kvartalsrapport 2014-Q2
2014-05-09 - X-dag ordinarie utdelning KARO 0.00 SEK
2014-05-08 - Årsstämma
2014-05-08 - Kvartalsrapport 2014-Q1
2014-03-17 - Extra Bolagsstämma 2014
2014-02-13 - Bokslutskommuniké 2013
2013-10-25 - Kvartalsrapport 2013-Q3
2013-07-12 - Kvartalsrapport 2013-Q2
2013-05-08 - X-dag ordinarie utdelning KARO 0.00 SEK
2013-05-07 - Årsstämma
2013-05-07 - Kvartalsrapport 2013-Q1
2013-03-13 - 15-7 2013
2013-02-12 - Analytiker möte 2013
2013-02-12 - Bokslutskommuniké 2012
2012-11-19 - Extra Bolagsstämma 2012
2012-10-24 - Kvartalsrapport 2012-Q3
2012-07-13 - Kvartalsrapport 2012-Q2
2012-06-12 - Årsstämma
2012-04-30 - X-dag ordinarie utdelning KARO 0.00 SEK
2012-04-27 - Kvartalsrapport 2012-Q1
2012-02-08 - Bokslutskommuniké 2011
2011-11-29 - 15-7 2011
2011-10-25 - Kvartalsrapport 2011-Q3
2011-07-13 - Kvartalsrapport 2011-Q2
2011-04-28 - X-dag ordinarie utdelning KARO 0.00 SEK
2011-04-27 - Årsstämma
2011-04-27 - Kvartalsrapport 2011-Q1
2011-02-09 - Bokslutskommuniké 2010
2010-10-26 - Kvartalsrapport 2010-Q3
2010-07-13 - Kvartalsrapport 2010-Q2
2010-04-26 - X-dag ordinarie utdelning KARO 0.00 SEK
2010-04-23 - Årsstämma
2010-04-22 - Kvartalsrapport 2010-Q1
2010-02-09 - Bokslutskommuniké 2009
2009-10-22 - Kvartalsrapport 2009-Q3
2009-07-14 - Kvartalsrapport 2009-Q2
2009-04-27 - X-dag ordinarie utdelning KARO 0.00 SEK
2009-04-24 - Årsstämma
2009-04-22 - Kvartalsrapport 2009-Q1

Beskrivning

LandSverige
SektorHälsovård
IndustriLäkemedel & Handel
Karo Pharma verkar inom vardagshälsa. Bolaget äger och kommersialiserar receptbelagda läkemedel och receptfria konsumentprodukter som säljs i apotek och detaljhandel samt via online-kanaler. Genom direkta försäljningsorganisationer och distributörsnätverk är bolagets produkter tillgängliga globalt, men med dess kärnverksamhet i Europa. Bolaget har sitt huvudkontor i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-16 14:00:00

Karo Healthcare ("Karo") has appointed Karine Martin as Chief Financial Officer and member of the Corporate Management Team.

 

Karine brings more than 20 years of international experience across all aspects of financial leadership, including commercial and corporate finance, financial planning and analysis, M&A, and large-scale transformation programmes. She began her career at Unilever and has since held senior finance roles at globally recognised companies such as GE Healthcare, Ecolab, Intertek and Electrolux.

 

Most recently, she served as CFO and Group Chief Financial and Transformation Officer at Stock Spirits Group, a CVC portfolio company. During her time there, she played a central role in shaping and delivering key efficiency and transformation initiatives, including the Fuel for Growth programme, strengthening the operating model and building a strong finance and transformation organisation to support the company's next phase of development.

 

"We are very pleased to welcome Karine to Karo. With her broad international experience, strong financial leadership and proven transformation track record, she will be instrumental in supporting Karo's continued development and further strengthening our financial platform. We are delighted to attract a CFO of Karine's calibre," says Christoffer Lorenzen, CEO.

 

"I'm excited to join Karo at such an important stage in its development. Karo has built a strong foundation and clear strategic direction. I'm passionate about efficiency and believe it starts with clarity. When processes are simpler and teams are empowered, performance improves naturally - and helping people grow is the part of my role I enjoy the most. I look forward to working closely with all Karo team members to further strengthen our financial capabilities and to position Finance and IT as business enablers of growth, speed, and better decisions," says Karine Martin.

 

Karine will take over from Egil Mølsted Madsen, who has successfully supported Karo through last year's exit process and transition to new owners. During his tenure, Egil has played an important role in strengthening Karo's financial platform and further establishing Finance as a strong business partner to the organisation.

 

Karine will assume her role at Karo in April and will be based at Karo's headquarters in Stockholm.

 

For further information, please contact:

Lisa Westerdahl, Chief People & Sustainability Officer, lisa.westerdahl@karo.com

 

The information was submitted for publication by the contact person set out above, at 14:00 CET on 16 March 2026.


About Karo Healthcare

Karo Healthcare is a leading European consumer healthcare company with the purpose of delivering "Smart choices for everyday healthcare", empowering people to live life to the fullest. Our products are available in more than 90 countries and include trusted original brands such as Lamisil®, E45®, Pevaryl®, Proct®, Nutravita, Flux®, Locobase®, Multi-Gyn® and Paracet®. Headquartered in Stockholm, Karo employs about 470 people who work out of Karo's 13 international hubs. For more info, visit karohealthcare.com.